Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 13/20 | 0.51 |
| ▸ | KDR | P35968 | 13/20 | 0.51 |
| ▸ | PDGFRB | P09619 | 12/20 | 0.51 |
| ▸ | FLT3 | P36888 | 4/20 | 0.49 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.49 |
| ▸ | CHEK1 | O14757 | 4/20 | 0.49 |
| ▸ | RET | P07949 | 3/20 | 0.49 |
| ▸ | FLT1 | P17948 | 3/20 | 0.49 |
| ▸ | AURKA | O14965 | 2/20 | 0.49 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.49 |
| ▸ | STK3 | Q13188 | 2/20 | 0.49 |
| ▸ | LCK | P06239 | 2/20 | 0.49 |
| ▸ | CSF1R | P07333 | 2/20 | 0.49 |
| ▸ | PHKG2 | P15735 | 2/20 | 0.49 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.49 |
| ▸ | AXL | P30530 | 2/20 | 0.49 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.49 |
| ▸ | GAK | O14976 | 1/20 | 0.49 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.49 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6322104 | 0.88 | KDR (0.47) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6328014 | 0.88 | KDR (0.54) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6323419 | 0.88 | KDR (0.54) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6321885 | 0.88 | KDR (0.54) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6323253 | 0.81 | EGFR (0.47) | FGFR1KDRPDGFRBFLT3ZAP70 | |
| SCHEMBL6320158 | 0.81 | ALK (0.52) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6323687 | 0.78 | MET (0.56) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6323692 | 0.78 | MET (0.56) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6322137 | 0.78 | KDR (0.43) | FGFR1KDRPDGFRBFLT3AURKB | |
| SCHEMBL6322336 | 0.77 | KDR (0.49) | FGFR1KDRPDGFRBFLT3AURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861418-B2 | 4-aryl substituted indolinones | SUGEN, INC. (US) | 2005-03-01 | — | — | US | disclosed |
| US-20040157909-A1 | 4-Aryl substituted indolinones | SUGEN, INC. | 2004-08-12 | — | — | US | disclosed |
| US-6677368-B2 | 4-aryl substituted indolinones | SUGEN, INC. | 2004-01-13 | — | — | US | disclosed |
| US-20030069297-A1 | 4-aryl substituted indolinones | SUGEN, INC. | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069297-A1 | 4-aryl substituted indolinones | CDK5, CAMK4, TNK2 | FGFR1 525/4885KDR 819/4885PDGFRB 575/4885 |
| US-20040157909-A1 | 4-Aryl substituted indolinones | CDK5, CAMK4, TNK2 | FGFR1 525/4885KDR 819/4885PDGFRB 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.